Cingulate Sets Sights On $18bn ADHD Market With Precision Timed-Release Approach

 
• By Ayisha Sharma
  
Emerging Company Profile: Cingulate
The ADHD Market Is Valued At Around $18bn • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Emerging Company Profiles

More from Start-Ups & SMEs